![\"Ethan](\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Basch-Ethan-Faculty-Photo.jpg\")
\nEthan Basch, MD, MSc<\/p>\n
\nEthan Basch, MD, MSc<\/p>\n
Dr. Ethan Basch<\/strong><\/em> is Physician-in-Chief of the North Carolina Cancer Hospital and Chief of Oncology at the University North Carolina, where he is the Richard M. Goldberg Distinguished Professor in Medical Oncology and Professor of Health Policy & Management. He has devoted his career to bringing the patient voice into cancer care delivery and drug development processes. His research group established that up to half of patients\u2019 symptomatic adverse events go undetected in clinical trials, and that patient-reported outcome questionnaires substantially improve detection. His team determined that integrating web-based patient-reported symptoms into oncology clinical practice improves clinical outcomes, including survival, and reduces health service utilization. His group created a system for the National Cancer Institute to collect patient-reported AEs during cancer trials called the \u2018PRO-CTCAE.\u2019 Dr. Basch is involved in efforts to bring PROs into comparative effectiveness research, routine care, and quality improvement. He is a member of the Board of Directors of the American Society of Clinical Oncology (ASCO), an Associate Editor at JAMA, and a prior member of the Board of Scientific Advisors for the National Cancer Institute (NCI) and the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI).<\/p>\n","protected":false},"excerpt":{"rendered":"